New Study from UCI & Nielsen Exploring the Hispanic Healthcare Journey Coming Soon

By Univision Team
Aug 11, 2016

Hispanic Healthcare Journey

Last month, UCI unveiled preliminary qualitative findings from the Hispanic Healthcare Journey at the Nielsen C360 Conference. UCI partnered with Nielsen to conduct the study as there is little understanding of the differences and similarities in healthcare behavior and attitudes between Hispanics and non-Hispanics. The study focuses on both the over-the-counter (OTC) and prescription medications markets.

These are some of the qualitative highlights we covered:

  • There is a need to improve Hispanics’ understanding of their health, especially chronic conditions. We heard from Hispanic respondents that if they do not feel ill, they consider themselves healthy, even after being diagnosed.
  • Hispanics diagnosed with chronic conditions still tend to be confused about the causes of their disease and how to manage their treatment.
  • Hispanics tend to rely on advertising for health information as well as family and friends.

The Hispanic Healthcare Journey was conducted in two phases. The first consisted of qualitative focus groups and shopalongs, and the second was a nationally representative quantitative survey.

Stay tuned as we’ll be unveiling findings from the quantitative phase of the Hispanic Healthcare Journey in the weeks to come. It will include Hispanic vs. non-Hispanic comparisons in:

  • attitudes and interactions towards healthcare professionals
  • perceptions of healthcare advertising
  • information seeking behaviors / sources of information
  • patient path to treatment for diabetes, high cholesterol, rheumatoid arthritis, COPD and ED
  • consumer path to purchase for OTC internal analgesics, vitamins, allergy, and cough/cold products

Related Articles


Univision NOW: What We’ve Learned Since 2015


Restaurant Leadership Conference: An Inside Look at How Dunkin’ Donuts Organizes to Win with Hispanics

Please enter a valid e-mail address.
Sign me up for

Thank you, you'll be receiving newsletter updates from us in your email inbox.